Isis Pharmaceuticals, Inc. Management Discusses Q4 2012 Results (Live Webcast)

Feb.28.13 | About: Ionis Pharmaceuticals, (IONS)
ISIS Pharmaceuticals (ISIS): Q4 EPS of -$0.03. Revenue of $19.9M beats by $4.12M. (PR)

The following audio is from an earnings conference call that began on February 28, 2013, at 12:00 PM ET. The audio is live-streaming while the call is active, and can be replayed upon its completion.